X

X

aescuvest and EIT Health launch first pan-European equity crowdfunding platform for healthcare

healthcare

 

aescuvest and EIT Health have launched the first pan-European equity crowdfunding platform for European healthcare companies.

aescuvest.eu aims to be the number one such platform dedicated to foster and fund innovations from European start-ups and SMEs in an end-to-end digital process, and allow companies to promote campaigns and EU citizens to invest across borders.

The platform will give both retail and institutional investors access to companies in the core health sectors of biotechnology, medical technology and digital health.

“We are very proud to have been chosen by EIT Health as the partner for this trailblazing project, that is in itself innovative in the financing and crowdfunding sector”, said Dr Patrick Pfeffer, CEO & Founder of aescuvest. “EIT Health activities are needs-driven and feature the engagement of future users and patients in the development, testing and scaling of solutions in co-creation environments.

aescuvest.eu plans o build a bridge between European citizens, healthcare professionals and healthcare innovators.”

Jan-Philipp Beck, CEO of EIT Health, added: “Crowdfunding stops at country borders these days. The cooperation with aescuvest.eu enables EIT Health to provide a unique service that will attract lots of start-ups and clearly differentiate us against any other accelerator. aescuvest.eu gives strong visibility, helps creating a bigger customer base, higher funding volume and therefore increased chances to succeed and to create impact. aescuvest’s specialisation, expert due diligence and excellent digital reach of professionals within the sector, combined with EIT Health’s incomparable access to hundreds of innovative companies, offers investors an exciting
investment opportunity.”

 

This Week’s Most Read

Latest IFA Magazine Podcast Episodes

Keep updated on the most important financial events 

Make sure you are an informed

wealth professional..

Adblock Blocker

We have detected that you are using

adblocking plugin in your browser. 

IFA Magazine